Novabay Pharmaceuticals (NBY) 0.56 $NBY
NovaBay to distribute prescription Avenova for blepharitis and dry eye to pharmacies across the US through Cardinal Health
M2 - Tue Jan 27, 3:07AM CST
Biopharmaceutical company NovaBay Pharmaceuticals (NYSE MKT:NBY) said on Monday that it has entered into a nationwide distribution agreement for Avenova with Cardinal Health (CAH), which delivers prescription drugs to retail pharmacies, hospitals, mail-order facilities, physician offices and surgery centres across the US.
NBY: 0.56 (unch)
NovaBay signs Avenova distribution agreement with Cardinal Health
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 6:12AM CST
MCK: 224.89 (+0.12), CAH: 86.08 (+0.04), NBY: 0.56 (unch)
NovaBay Signs Avenova Distribution Agreement with Cardinal Health
Business Wire - Mon Jan 26, 6:02AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that it has signed a nationwide distribution agreement with Cardinal Health (NYSE: CAH), which delivers prescription drugs and many other products to retail pharmacies, hospitals, mail-order facilities, physician offices, surgery centers and other facilities across the U.S.
MCK: 224.89 (+0.12), CAH: 86.08 (+0.04), NBY: 0.56 (unch)
NovaBay Will Expand Marketing for Avenova At Arab Health 2015
ACCESSWIRE - Fri Jan 23, 6:00AM CST
NovaBay Pharmaceuticals will expand marketing and seek partners for Avenova at the world's largest healthcare conference
NBY: 0.56 (unch)
NovaBay Management and Key Industry Opinion Leaders to Hold Investment Community Conference Call Today, January 21st, 2015, at 12:00 p.m. ET
Business Wire - Wed Jan 21, 6:00AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company developing and commercializing non-antibiotic anti-infective products, will host an investment community conference call. Management will discuss the Company's refined business focus on products for the eye care market announced January 7, 2015, and sales force expansion announced January 20, 2015.
NBY: 0.56 (unch)
NovaBay Expands Sales Force for Avenova
Business Wire - Tue Jan 20, 1:38PM CST
--NovaBay management and key industry opinion leaders to hold an investment community conference call tomorrow, January 21st, at 12:00 p.m. Eastern time
NBY: 0.56 (unch)
NovaBay revamps strategy to focus on Eye Care
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:36AM CST
NBY: 0.56 (unch)
NovaBay Announces New Business Strategy Focusing on Products for Eye Care
Business Wire - Wed Jan 07, 6:00AM CST
--Seeking strategic alternatives for wound care, urology and dermatology assets
NBY: 0.56 (unch)
NovaBay Rebrands Its i-Lid Cleanser as Avenova
Business Wire - Mon Jan 05, 6:01AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of topical non-antibiotic anti-infective products, announces the rebranding of its i-Lid Cleanser with Neutrox(TM) as Avenova(TM) with Neutrox. This name change, effective immediately, helps NovaBay to differentiate prescription Avenova from other products marketed as eye cleaners, in particular over-the-counter (OTC) products not intended for continuous daily use.
NBY: 0.56 (unch)
Insider Trading Alert - NBY, WPX And KTOS Traded By Insiders
at The Street - Wed Dec 17, 10:42AM CST
Stocks with insider trader activity include NBY, WPX and KTOS
WPX: 12.60 (-0.04), KTOS: 5.69 (+0.03), NBY: 0.56 (unch)
Insider Trading Alert - EVTC, CRM And NBY Traded By Insiders
at The Street - Tue Dec 16, 10:38AM CST
Stocks with insider trader activity include EVTC, CRM and NBY
EVTC: 20.90 (-0.08), NBY: 0.56 (unch), CRM: 62.85 (+1.59)
NovaBay Executive Officers Report Insider Buying of 143,000 Common Shares to the SEC
ACCESSWIRE - Tue Dec 16, 6:00AM CST
EMERYVILLE, CA / ACCESSWIRE / December 16, 2014 / NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY) reported that between December 2 and 12, 2014, NovaBay's CEO, CFO and Senior Vice President have filed Form 4's with the Security and Exchange Commission reporting their combined purchases of 143,000 shares of NovaBay common stock in open market purchases. During one the company's infrequent and brief open trading windows for insiders, NovaBay's CEO, Dr. Ron Najafi, purchased over 113,000 shares, the Company's CFO, Tom Paulson, purchased 20,000 shares and NovaBay's Senior Vice President of Ophthalmology, Dr. David Stroman, purchased 10,000 shares. Shares were purchased at prices ranging between $0.60 and $0.71; prices the Officers believe are a substantial discount to NovaBay's potential long term value.
NBY: 0.56 (unch)
Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders
at The Street - Fri Dec 12, 10:15AM CST
Stocks with insider trader activity include CGIX, NBY and BIOA
BIOA: 9.21 (+0.16), NBY: 0.56 (unch), CGIX: 7.07 (unch)
Insider Trading Alert - GNMK, RLOG And NBY Traded By Insiders
at The Street - Tue Dec 09, 10:38AM CST
Stocks with insider trader activity include GNMK, RLOG and NBY
GNMK: 13.51 (+0.21), RLOG: 3.59 (unch), NBY: 0.56 (unch)
NovaBay Signs Distribution Agreement With the Biopharm Group
Business Wire - Mon Dec 08, 6:00AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that it has signed an exclusive distribution agreement for NovaBay's NeutroPhase(R) Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt.
NBY: 0.56 (unch)
Insider Trading Alert - ARCW, CVV And NBY Traded By Insiders
at The Street - Fri Dec 05, 9:15AM CST
Stocks with insider trader activity include ARCW, CVV and NBY
ARCW: 6.62 (+0.23), CVV: 14.68 (-0.26), NBY: 0.56 (unch)
Insider Trading Alert - NBY, WRES And ABTL Traded By Insiders
at The Street - Thu Dec 04, 9:30AM CST
Stocks with insider trader activity include NBY, WRES and ABTL
ABTL: 9.88 (+0.13), WRES: 1.27 (+0.01), NBY: 0.56 (unch)
NovaBay's i-Lid Cleanser Featured in Review of Optometry
ACCESSWIRE - Tue Dec 02, 6:00AM CST
NovaBay's product brings "substantial improvement" when used to treat blepharitis, the article reports
NBY: 0.56 (unch)
NovaBay Pharmaceuticals will attend Annual LD MICRO Conference
ACCESSWIRE - Mon Dec 01, 6:01AM CST
NovaBay CEO Ron Najafi anticipates useful meetings at invitation-only conference
NBY: 0.56 (unch)
NovaBay to distribute prescription Avenova for blepharitis and dry eye to pharmacies across the US through Cardinal Health
M2 - Tue Jan 27, 3:07AM CST
Biopharmaceutical company NovaBay Pharmaceuticals (NYSE MKT:NBY) said on Monday that it has entered into a nationwide distribution agreement for Avenova with Cardinal Health (CAH), which delivers prescription drugs to retail pharmacies, hospitals, mail-order facilities, physician offices and surgery centres across the US.
NBY: 0.56 (unch)
NovaBay signs Avenova distribution agreement with Cardinal Health
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 6:12AM CST
MCK: 224.89 (+0.12), CAH: 86.08 (+0.04), NBY: 0.56 (unch)
NovaBay Signs Avenova Distribution Agreement with Cardinal Health
Business Wire - Mon Jan 26, 6:02AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that it has signed a nationwide distribution agreement with Cardinal Health (NYSE: CAH), which delivers prescription drugs and many other products to retail pharmacies, hospitals, mail-order facilities, physician offices, surgery centers and other facilities across the U.S.
MCK: 224.89 (+0.12), CAH: 86.08 (+0.04), NBY: 0.56 (unch)
NovaBay Will Expand Marketing for Avenova At Arab Health 2015
ACCESSWIRE - Fri Jan 23, 6:00AM CST
NovaBay Pharmaceuticals will expand marketing and seek partners for Avenova at the world's largest healthcare conference
NBY: 0.56 (unch)
NovaBay Management and Key Industry Opinion Leaders to Hold Investment Community Conference Call Today, January 21st, 2015, at 12:00 p.m. ET
Business Wire - Wed Jan 21, 6:00AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company developing and commercializing non-antibiotic anti-infective products, will host an investment community conference call. Management will discuss the Company's refined business focus on products for the eye care market announced January 7, 2015, and sales force expansion announced January 20, 2015.
NBY: 0.56 (unch)
NovaBay Expands Sales Force for Avenova
Business Wire - Tue Jan 20, 1:38PM CST
--NovaBay management and key industry opinion leaders to hold an investment community conference call tomorrow, January 21st, at 12:00 p.m. Eastern time
NBY: 0.56 (unch)
NovaBay revamps strategy to focus on Eye Care
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:36AM CST
NBY: 0.56 (unch)
NovaBay Announces New Business Strategy Focusing on Products for Eye Care
Business Wire - Wed Jan 07, 6:00AM CST
--Seeking strategic alternatives for wound care, urology and dermatology assets
NBY: 0.56 (unch)
NovaBay Rebrands Its i-Lid Cleanser as Avenova
Business Wire - Mon Jan 05, 6:01AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of topical non-antibiotic anti-infective products, announces the rebranding of its i-Lid Cleanser with Neutrox(TM) as Avenova(TM) with Neutrox. This name change, effective immediately, helps NovaBay to differentiate prescription Avenova from other products marketed as eye cleaners, in particular over-the-counter (OTC) products not intended for continuous daily use.
NBY: 0.56 (unch)
Insider Trading Alert - NBY, WPX And KTOS Traded By Insiders
at The Street - Wed Dec 17, 10:42AM CST
Stocks with insider trader activity include NBY, WPX and KTOS
WPX: 12.60 (-0.04), KTOS: 5.69 (+0.03), NBY: 0.56 (unch)
Insider Trading Alert - EVTC, CRM And NBY Traded By Insiders
at The Street - Tue Dec 16, 10:38AM CST
Stocks with insider trader activity include EVTC, CRM and NBY
EVTC: 20.90 (-0.08), NBY: 0.56 (unch), CRM: 62.85 (+1.59)
NovaBay Executive Officers Report Insider Buying of 143,000 Common Shares to the SEC
ACCESSWIRE - Tue Dec 16, 6:00AM CST
EMERYVILLE, CA / ACCESSWIRE / December 16, 2014 / NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY) reported that between December 2 and 12, 2014, NovaBay's CEO, CFO and Senior Vice President have filed Form 4's with the Security and Exchange Commission reporting their combined purchases of 143,000 shares of NovaBay common stock in open market purchases. During one the company's infrequent and brief open trading windows for insiders, NovaBay's CEO, Dr. Ron Najafi, purchased over 113,000 shares, the Company's CFO, Tom Paulson, purchased 20,000 shares and NovaBay's Senior Vice President of Ophthalmology, Dr. David Stroman, purchased 10,000 shares. Shares were purchased at prices ranging between $0.60 and $0.71; prices the Officers believe are a substantial discount to NovaBay's potential long term value.
NBY: 0.56 (unch)
Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders
at The Street - Fri Dec 12, 10:15AM CST
Stocks with insider trader activity include CGIX, NBY and BIOA
BIOA: 9.21 (+0.16), NBY: 0.56 (unch), CGIX: 7.07 (unch)
Insider Trading Alert - GNMK, RLOG And NBY Traded By Insiders
at The Street - Tue Dec 09, 10:38AM CST
Stocks with insider trader activity include GNMK, RLOG and NBY
GNMK: 13.51 (+0.21), RLOG: 3.59 (unch), NBY: 0.56 (unch)
NovaBay Signs Distribution Agreement With the Biopharm Group
Business Wire - Mon Dec 08, 6:00AM CST
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that it has signed an exclusive distribution agreement for NovaBay's NeutroPhase(R) Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt.
NBY: 0.56 (unch)
Insider Trading Alert - ARCW, CVV And NBY Traded By Insiders
at The Street - Fri Dec 05, 9:15AM CST
Stocks with insider trader activity include ARCW, CVV and NBY
ARCW: 6.62 (+0.23), CVV: 14.68 (-0.26), NBY: 0.56 (unch)
Insider Trading Alert - NBY, WRES And ABTL Traded By Insiders
at The Street - Thu Dec 04, 9:30AM CST
Stocks with insider trader activity include NBY, WRES and ABTL
ABTL: 9.88 (+0.13), WRES: 1.27 (+0.01), NBY: 0.56 (unch)
NovaBay's i-Lid Cleanser Featured in Review of Optometry
ACCESSWIRE - Tue Dec 02, 6:00AM CST
NovaBay's product brings "substantial improvement" when used to treat blepharitis, the article reports
NBY: 0.56 (unch)
NovaBay Pharmaceuticals will attend Annual LD MICRO Conference
ACCESSWIRE - Mon Dec 01, 6:01AM CST
NovaBay CEO Ron Najafi anticipates useful meetings at invitation-only conference
NBY: 0.56 (unch)
